AOT water-in-oil microemulsions as a penetration enhancer in transdermal drug delivery of 5-fluorouracil

Colloids and Surfaces B: Biointerfaces

Volumn 41, Issue 1, 2005, Pages 25-32

  Gupta, Reeta R ^a   Jain, Swantrant K ^a   Varshney, Manoj ^a,b  

^a HAMDARD UNIVERSITY   (India)

^b UNIVERSITY OF FLORIDA   (United States)

Author keywords

5 Fluorouracil; AOT; ATR FTIR; Microemulsion; Transdermal drug delivery

Indexed keywords

AEROSOLS; CELLS; CHEMICAL MODIFICATION; CONTROLLED DRUG DELIVERY; DIFFUSION; ENCAPSULATION; FOURIER TRANSFORM INFRARED SPECTROSCOPY; HYDRATION; HYDROPHILICITY; OILS AND FATS; PERTURBATION TECHNIQUES; SKIN; TOXICITY; WATER;

ATTENUATED TOTAL REFLECTANCE (ATR); DRUG DELIVERY; DRUG ENCAPSULATION; STRATUM CORNEUM (SC);

MICROEMULSIONS;

ANIONIC SURFACTANT; ANTINEOPLASTIC AGENT; DOCUSATE SODIUM; FLUOROURACIL; LIPID; MYRISTIC ACID ISOPROPYL ESTER; PENETRATION ENHANCING AGENT; WATER OIL CREAM;

ANIMAL TISSUE; AQUEOUS SOLUTION; ARTICLE; CHEMICAL MODIFICATION; CONTROLLED STUDY; CORNEA CELL; DRUG CAPSULE; DRUG DELIVERY SYSTEM; DRUG DIFFUSION; DRUG EFFECT; DRUG PENETRATION; DRUG SAFETY; EXAMINATION; HYDRATION; HYDROPHILICITY; INFRARED SPECTROSCOPY; LIQUID CULTURE; MALE; MICROEMULSION; MICROENCAPSULATION; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; SKIN IRRITATION; SKIN PERMEABILITY; STRATUM CORNEUM; WATER CONTENT; WEIGHT;

ADMINISTRATION, CUTANEOUS; ANIMALS; ANTIMETABOLITES, ANTINEOPLASTIC; DIOCTYL SULFOSUCCINIC ACID; EMULSIONS; FLUOROURACIL; MALE; MICE; MYRISTATES; SKIN; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; SURFACE-ACTIVE AGENTS; WATER;

EID: 13444306287     PISSN: 09277765     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.colsurfb.2004.09.008     Document Type: Article

References (49)

1. S.E.R. Cross, and M.S. Current Drug Delivery 1 2004 81 92
2. A.S. Ulrich Biosci. Rep. 22 2002 129 150
3. H.D.C. Smyth, C. Becket, and S. Mehta J. Pharm. Sci. 91 2002 1296 1307
4. Y.S.R. Krishnaiah, V. Satyanarayana, and R.S. Karthikeyan Pharm. Dev. Technol. 7 2002 305 315
5. T. Cerchiara, B. Luppi, F. Bigucci, I. Orienti, and V. Zecchi J. Pharm. Pharmacol. 54 2002 1453 1459
6. L. Mooreand, and Y.W. Chien Crit. Rev. Ther. Drug Carrier Syst. 4 1988 285 349
7. A.C. Williamsand, and B.W. Barry Crit. Rev. Ther. Drug Carrier Syst. 9 1992 305 353
8. J. Jaiswal, R. Poduri, and R. Panchagnula Int. J. Pharm. 179 1999 129 134
9. C.S. Asbill, A.F. El-Kattan, and B. Michniak Crit. Rev. Ther. Drug Carrier Syst. 17 2000 621 658
10. E.S. Park, S.Y. Chang, M.Y. Hahn, and S.C. Chi Int. J. Pharm. 209 2000 109 119
11. V.R. Sinhaand, and M.P. Kaur Drug Dev. Ind. Pharm. 26 2000 1131 1140
12. A.C. Williamsand, and B.W. Barry Adv. Drug Delivery Rev. 56 2004 603 618
13. S. Peltola, P. Saarinen-Savolainen, J. Kiesvaara, T.M. Suhonen, and A. Urtti Int. J. Pharm. 254 2003 99 107
14. Z. Mei, H. Chen, T. Weng, Y. Yang, and X. Yang Eur. J. Pharm. Biopharm. 56 2003 189 196
15. P.J. Lee, R. Langer, and V.P. Shastri Pharm. Res. 20 2003 264 269
16. S. Kantaria, G.D. Rees, and M.J. Lawrence Int. J. Pharm. 250 2003 65 83
17. D.W. Osborne, A.J. Ward, and K.J. O'Neill J. Pharm. Pharmacol. 43 1991 450 454
18. M. Varshney, T. Khanna, and M. Changez Colloids Surf. B: Biointerfaces 13 1999 1 11
19. M. Changezand, and M. Varshney Drug Dev. Ind. Pharm. 26 2000 507 512
20. R.G. Hahn, C.G. Moertel, A.J. Schutt, and H.W. Bruckner Cancer 35 1975 1031 1035
21. R.B. Diasioand, and B.E. Harris Clin. Pharmacokinet. 16 1989 215 237
22. M. Goodmanand, and B.W. Barry J. Invest. Dermatol. 91 1988 323 327
23. W.J. Robertsand, and K.B. Sloan Topical delivery of 5-fluorouracil (5-FU) by 3-alkylcarbonyloxymethyl-5-FU prodrugs J. Pharm. Sci. 92 2003 1028 1036
24. H. Sasaki, M. Kojima, Y. Mori, J. Nakamura, and J. Shibasaki J. Pharm. Sci. 80 1991 533 538
25. E.F. Sherertz, K.B. Sloan, and R.G. McTiernan Arch. Dermatol. Res. 282 1990 463 468
26. K.B. Sloan, S. Wasdo, U. Ezike-Mkparu, T. Murray, D. Nickels, S. Singh, T. Shanks, J. Tovar, K. Ulmer, and R. Waranis Pharm. Res. 20 2003 639 645
27. H.E. Taylorand, and K.B. Sloan J. Pharm. Sci. 87 1998 15 20
28. A. Maitra, C. Mathew, and M. Varshney J. Phys. Chem. 94 1990 5290 5292
29. Y.W. Chein Transdermal Controlled Systemic Medications 1987 Marcel Dekker New York 127
30. F. Dreher, P. Walde, P. Walther, and E. Wehrli J. Contr. Release 45 1997 131 140
31. A. Jadoul, J. Bouwstra, and V. Preat Adv. Drug Delivery Rev. 35 1999 89 105
32. R.O. Potts, G.M. Golden, M.L. Francoeur, V.H.W. Mak, and R.H. Guy. J. Contr. Release 15 1991 249 260
33. M.V.A. Uttley J. Soc. Cosmet. Chem. 24 1973 217 227
34. D.E. Wursterand, and S.F. Kramer J. Pharm. Sci. 50 1961 288 293
35. K.S. Bhatia, S. Gao, and J. Singh J. Contr. Release 47 1997 81 89
36. M. Branagan, D.H. Chenery, and S. Nicholson Skin Pharmacol. Appl. Skin Physiol. 13 2000 157 164
37. H.C. Chen, R. Mendelsohn, M.E. Rerek, and D.J. Moore Biochim. Biophys. Acta: Biomembr. 1468 2000 293 303
38. P.A.D. Edwardson, M. Walker, and C. Breheny Int. J. Pharm. 91 1993 51 57
39. M. Gloor, G. Hirsch, and U. Willebrandt Arch. Dermatol. Res. 271 1981 305 313
40. H.M. Heise, L. Kupper, and L.N. Butvina J. Mol. Struct. 661 2003 381 389
41. C. Laugel, C. Do Nascimento, D. Ferrier, J.P. Marty, and A. Baillet Appl. Spectrosc. 55 2001 1173 1180
42. M. Mimeaultand, and D. Bonenfant Talanta 56 2002 395 405
43. D.J. Moore, M.E. Rerek, and R. Mendelsohn Biophys. J. 72 1997 Th335
44. R.O. Potts, D.B. Guzek, R.R. Harris, and J.E. Mckie Arch. Dermatol. Res. 277 1985 489 495
45. G.M. Golden, D.B. Guzek, A.H. Kennedy, J.E. McKie, and R.O. Potts Biochemistry 26 1987 2382 2388
46. G.M. Golden, J.E. McKie, and R.O. Potts J. Pharm. Sci. 76 1987 25 28
47. M. Kreilgaard, E.J. Pedersen, and J.W. Jaroszewski J. Contr. Release 69 2000 421 433
48. A.C. Williamsand, and B.W. Barry Crit. Rev. Ther. Drug Carrier. Syst. 9 1992 305 353
49. A.K. Levang, K. Zhao, and J. Singh Int. J. Pharm. 181 1999 255 263